Life Sciences Review

About Us

Conference

Partner With Us

Drug Discovery and Development

New Innovative Probiotics Reduces Risk of Aspirin-Induced Ulcers

Anders Damholt

PhD Biochemistry, Head of Clinical Development Human Health Innovation & Sara Engel, PhD Human Nutrition, Senior Clinical Development Scientist

Human Health Innovation

Improving Epilepsy Treatment Through Better Formulation

Andy Stewart

Managing Director

Desitin Pharma Ltd

Featured Issue

Featured Categories

Gynecology and Neurology Medicine Development

Smart Drug Product Formulation Service

Digitally Democratizing Healthcare

Felipe Cezar Cabral, Gerente Médico de Saúde Digital [Digital Health Medical Manager] Hospital Moinhos de Vento

How Can We Tackle the Health Equity Gap to Innovative Medicines?

Silvy Mardiguian, PhD Market Access Director BeiGene

Gynecology And Neurology Medicine Development

A Century of Medical Legacy, Built on Original Therapies

Marco Bertini, R&D and Medical Affairs Manager Laboratori Baldacci S.p.A

Smart Drug Product Formulation Service

Turning Formulation into the New R&D Frontier in Pharma

Dr. Mathias Scheer, Founder and CEO Emoviar PharmaCon

Discovering the Medicines of the Future

Araz Raoof, Senior Vice President Global Drug Discovery & External Innovation

Ferring Pharmaceuticals

Accelerating Clinical Trials Through Real-Time Data Analytics and Adaptive Decision-Making

An Interview with Katy Moore Pharm. D., R.Ph., President, Clinical Pharmacology Modelling and Simulation; and Alex MacDonald Ph.D., M.Sc., Vice President of Model-Informed Drug Development (MIDD), Allucent

Building a More Dependable Route to Medicine Access

Colm Moynihan, President

Evumed Limited

News

Hospital-Based Stem Cell Programs Highlight the Access Challenge

Elevating Patient Care: The Impact of AI on Prognostic Testing

Evidence before Expansion in Stem Cell Therapy

Molecular Pathology Built Around Clinical Context

Drug Development for Rare Diseases

Fabiana d’Aniello, R&D Portfolio Management Director

Ferrer

The Next Technological Advancement in Resin Development

Sofie Stille, Vice President of Technology,

Cytiva

Improving Cardiovascular Outcomes

Anders Kronborg, CEO

Fast Track The Drug Discovery Journey With ALPX

Irina Cornaciu-Hoffmann, CEO and Co-Founder

Specials

Drug Discovery and Development

New Innovative Probiotics Reduces Risk of Aspirin-Induced Ulcers

Improving Epilepsy Treatment Through Better Formulation

Featured Issue

Featured Categories

Gynecology and Neurology Medicine Development

Smart Drug Product Formulation Service

Digitally Democratizing Healthcare

How Can We Tackle the Health Equity Gap to Innovative Medicines?

A Century of Medical Legacy, Built on Original Therapies

Turning Formulation into the New R&D Frontier in Pharma

Discovering the Medicines of the Future

Accelerating Clinical Trials Through Real-Time Data Analytics and Adaptive Decision-Making

Building a More Dependable Route to Medicine Access

News

Hospital-Based Stem Cell Programs Highlight the Access Challenge

Elevating Patient Care: The Impact of AI on Prognostic Testing

Evidence before Expansion in Stem Cell Therapy

Molecular Pathology Built Around Clinical Context

Drug Development for Rare Diseases

The Next Technological Advancement in Resin Development

Improving Cardiovascular Outcomes

Fast Track The Drug Discovery Journey With ALPX

Unveiling a Game-Changer in Parkinson's Treatment

Unlocking Novel First-In-Class Drug Discovery with Collaborative Innovation

Navigating the Frontiers of Pharmaceutical Advancements

Developing Next-Generation Anti-Thrombotics

Digital Innovation

Innovation Vs Validation in Early Drug Discovery

Transforming Healthcare: The Crucial Role Of Diagnostic Radiology In Influencing Patient Experience And Outcomes

News

European Drug Developers Reassess Manufacturing Partnerships as Generic and Biopharmaceutical Pipelines Grow More Complex

Development Expertise Becomes a Deciding Factor in European Pharmaceutical Outsourcing

European Development Providers Balance Capacity Expansion With Long-Term Scientific Investment

The Next Frontier in European Pharmaceutical Formulations